Myeloid Derived Suppressor and Dendritic Cell Subsets Are Related to Clinical Outcome in Prostate Cancer Patients Treated With Prostate GVAX and Ipilimumab
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-014-0031-3
Full Text
Open PDFAbstract
Available in full text
Date
September 16, 2014
Authors
Publisher
BMJ